Matthews v. Storgion

335 F. Supp. 2d 878, 2004 U.S. Dist. LEXIS 18653, 2004 WL 2072368
CourtDistrict Court, W.D. Tennessee
DecidedSeptember 9, 2004
Docket03-2600-D
StatusPublished
Cited by2 cases

This text of 335 F. Supp. 2d 878 (Matthews v. Storgion) is published on Counsel Stack Legal Research, covering District Court, W.D. Tennessee primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Matthews v. Storgion, 335 F. Supp. 2d 878, 2004 U.S. Dist. LEXIS 18653, 2004 WL 2072368 (W.D. Tenn. 2004).

Opinion

*881 ORDER DENYING IN PART AND GRANTING IN PART DEFENDANTS’ MOTION TO DISMISS OR IN THE ALTERNATIVE FOR SUMMARY JUDGMENT

DONALD, District Judge.

Before the Court is the motion of Stephanie A. Storgion, M.D.; Teresa J. Sig-mon; Sigmon Law Firm; and State Volunteer Mutual Insurance Company (“SVMIC”) (collectively “Defendants”) to dismiss the complaint or in the alternative for summary judgment. LaMarquist Matthews, a minor by and through the legal guardian of his estate; Danny J. Barfield, Agent for HD Vest Financial Services; the Law Firm of Gary, Williams, Parenti, Fin-ney, Lewis, McManus, Watson & Speran-do; and the Law Firm of Meador & Crump (collectively “Plaintiffs”) assert claims for 1) abuse of process, 2) intentional interference with a business relationship, 3) inducement and procurement of breach of contract, 4) coercion of a witness, and 5) for punitive damages for intentional, malicious, and reckless conduct. Defendants propound numerous arguments in favor of summary judgment. 1 This Court has jurisdiction pursuant to 28 U.S.C. § 1331. For the reasons stated herein, the Court GRANTS IN PART AND DENIES IN PART Defendants’ motion for summary judgment.

I. FACTUAL AND PROCEDURAL BACKGROUND 2

On September 14, 1998, a medical malpractice action was initiated in the state courts by Danny J. Barfield, the legal guardian of the estate of LaMarquist Matthews, on Matthews’ behalf against Le-Bonheur Children’s Medical Center; Gregory Stidham, M.D.; U.T. Medical Group, and Jane or John Doe # 1-6. On November 4, 1999, Stephanie Storgion, M.D., was added as a defendant.

Teresa J. Sigmon and the Sigmon Law Firm were retained by SVMIC, Dr. Stor-gion’s professional liability insurance carrier, to represent Dr. Storgion in the malpractice suit. The law firms of Gary, Williams, Parenti, Finney, Lewis, Mc-Manus, Watson & Sperando, and Meador & Crump were retained to represent Matthews, by and through his legal guardian. Thereafter, the law firms employed by Matthews’ guardian retained the services of Walter Scott, Ph.D. Dr. Scott was initially disclosed to be an expert witness. In 1999, for the first time, the defendants in the malpractice case attempted to have Dr. Scott excluded as an expert witness based on his lack of experience in treating patients with the medical device at issue. The state court determined that Dr. Scott would not be considered an expert for the purpose of testifying as to the applicable standard of care.

After the state court’s ruling, Ms. Sig-mon deposed Dr. Scott on July 6, 2000. During the deposition, Dr. Scott stated that he was employed by the Food and Drug Administration (“FDA”). He further told Ms. Sigmon that he was prohibited by the FDA from testifying as an expert witness, however, he was working for the plaintiffs in the capacity of a fact witness and/or consultant for which he received $175 per hour for his work. Dr. Scott stated that his testimony related to *882 the use of the medical device in question and would not include any medical opinions as he was not a medical doctor. He told Ms. Sigmon that he had completed a form for outside activity which was then submitted to the ethics department and that he had received approval from the FDA to serve as a consultant and as a fact witness for the plaintiffs. Dr. Scott asserted that in the request form he had described his role as “serving as a consultant and a witness of fact in a civil liability case involving a medical device that [he] work[ed] with. And, [he] was relying upon [his] experience and [ ] education.” Dr. Scott stated that he believed that his request was approved. Dr. Scott told Ms. Sigmon that he had not disagreed to testify in the case, however, he had to determine whether the FDA policy would allow him to do so.

On December 3, 2001, the defendants in the malpractice case again sought to exclude Dr. Scott from testifying at trial, asserting that he was not qualified to testify as to the recognized standard of acceptable professional practice. The plaintiffs responded that Dr. Scott would not testify as to the acceptable professional practice, but instead would offer facts regarding the federal government’s efforts to educate the medical community regarding the complications and risks of malpositioning the medical device at issue. The defendants then filed another motion in limine to exclude the testimony of Dr. Scott, asserting that his testimony, in effect, related to the applicable standard of care. The state court denied the motions.

On August 15, 2002, Ms. Sigmon emailed Dr. Scott’s supervisor at the FDA, requesting a copy of any file containing the FDA’s approval for Dr. Scott to be involved in the case along with any other items related in any way to Dr. Scott’s involvement in the case or in any other case. She also requested all internal documents that outlined the parameters for FDA employees’ participation in litigation. On August 27, 2002, Ms. Sigmon contacted Lana Ogram of the FDA via correspondence again seeking information concerning FDA regulations related to their employees offering testimony along with information pertaining to Dr. Scott. She also mailed Ms. Ogram a copy of the deposition. Ms. Sigmon contacted Ms. Ogram on October 24 and December 23, 2002 and January 27, 2003, regarding her August 27, 2002 correspondence.

On January 9, 2003, Dr. Scott sent the plaintiffs in the malpractice case a letter in which he withdrew his services, stating that his employer informed him that he should not give “testimony” in outside legal contests that may involve the FDA. In the letter, Dr. Scott stated that “Teresa Sigmon’s inquiry has apparently raised the specter of the possible impression of wrong-doing on [his] part....” On January 15, 2003, the plaintiffs filed a motion in which they complained that the defendants’ conduct resulted in the withdrawal of Dr. Scott’s assistance in the case. A hearing on the motion was held on January 31, 2003. Despite Dr. Scott’s withdrawal from the case, the court did not rule on the appropriateness of Ms. Sig-mon’s conduct.

On January 30, March 25, April 7, and May 13, 2003, Ms. Sigmon again contacted Ms. Ogram regarding the status of her August 2002 request. On May 31, 2003, Ann Curtsinger of the FDA responded to Ms. Sigmon indicating that her request was partially completed and that more materials would follow. On August 22, 2003, Darlene Christian of the FDA responded to Ms. Sigmon informing her that although Dr. Scott’s personnel records were enclosed, his personal information, such as his social security number, was redacted. *883 Ms. Sigmon appealed the denial of this Information.

The plaintiffs in the malpractice claim retained an individual to replace Dr. Scott. Thereafter, Plaintiffs filed the instant action based on Ms. Sigmon’s conduct in the malpractice lawsuit.

Defendants filed a motion for summary judgment in December 2003 and since have filed seven supplemental memoranda. Plaintiffs filed a response on August 20, 2004.

II. STANDARD FOR SUMMARY JUDGMENT

Free access — add to your briefcase to read the full text and ask questions with AI

Related

H Group Construction, LLC v. City of Lafollette
Court of Appeals of Tennessee, 2019
Captain Louis J. Gillespie, Jr. v. City of Memphis
Court of Appeals of Tennessee, 2008

Cite This Page — Counsel Stack

Bluebook (online)
335 F. Supp. 2d 878, 2004 U.S. Dist. LEXIS 18653, 2004 WL 2072368, Counsel Stack Legal Research, https://law.counselstack.com/opinion/matthews-v-storgion-tnwd-2004.